Bausch Health Companies Inc.
BHCNYSETrackedMarket Data VerifiedHealth CarePharmaceuticals
- Coverage
- Coverage universe Identity published; no third-party ESG observation yet.
- ESG profile reviewed
- Last editorial update to this profile.
- Quote
- Last verified closeObservation time is shown beside the price.
- Methodology
- How we rateProvider ratings are shown separately, never blended.
Market overview
Up+USD 0.61 (+9.67%) Day change
The market is closed. This is the last verified closing quote, not an intraday price.
- Open
- USD 6.29
- Previous close
- USD 6.31
- Day high
- USD 6.97
- Day low
- USD 6.25
- Volume
- 7,995,569
- Market cap
- USD 2,588,014,592
View Chart Data
| Date and time | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| USD 6.23 | USD 6.27 | USD 6.16 | USD 6.20 | 1,273,600 | |
| USD 6.32 | USD 6.38 | USD 6.24 | USD 6.25 | 2,065,100 | |
| USD 7.05 | USD 7.10 | USD 6.91 | USD 6.92 | 1,541,400 | |
| USD 7.18 | USD 7.25 | USD 7.10 | USD 7.13 | 1,158,400 | |
| USD 7.71 | USD 8.00 | USD 7.64 | USD 7.90 | 2,142,900 | |
| USD 7.55 | USD 7.73 | USD 7.42 | USD 7.45 | 1,298,000 | |
| USD 5.59 | USD 5.74 | USD 5.55 | USD 5.74 | 2,243,700 | |
| USD 6.05 | USD 6.12 | USD 5.96 | USD 5.99 | 1,971,900 | |
| USD 5.75 | USD 5.77 | USD 5.57 | USD 5.63 | 2,137,600 | |
| USD 5.01 | USD 5.10 | USD 4.95 | USD 5.03 | 1,495,400 | |
| USD 5.38 | USD 5.44 | USD 5.33 | USD 5.41 | 735,300 | |
| USD 5.89 | USD 5.92 | USD 5.71 | USD 5.73 | 1,503,500 | |
| USD 5.55 | USD 5.73 | USD 5.55 | USD 5.64 | 1,290,600 | |
| USD 5.31 | USD 5.61 | USD 5.24 | USD 5.50 | 1,876,900 | |
| USD 5.27 | USD 5.39 | USD 5.16 | USD 5.37 | 1,840,500 | |
| USD 4.69 | USD 4.80 | USD 4.67 | USD 4.80 | 1,222,600 | |
| USD 4.89 | USD 4.91 | USD 4.80 | USD 4.86 | 1,551,100 | |
| USD 4.48 | USD 4.50 | USD 4.41 | USD 4.43 | 1,227,000 | |
| USD 6.31 | USD 6.54 | USD 6.16 | USD 6.35 | 2,801,000 | |
| USD 6.74 | USD 6.74 | USD 6.46 | USD 6.73 | 3,455,700 | |
| USD 6.38 | USD 6.47 | USD 6.14 | USD 6.16 | 1,424,900 | |
| USD 5.67 | USD 5.78 | USD 5.54 | USD 5.65 | 2,020,400 | |
| USD 6.05 | USD 6.17 | USD 6.02 | USD 6.04 | 1,032,800 | |
| USD 6.53 | USD 6.45 | USD 6.27 | USD 6.40 | 642,573 |
Company Profile & Business Model Overview
Sustainability Strengths & Catalysts (Pros)
- Bausch Health operates a diversified portfolio across gastroenterology, dermatology, and eye health, providing some revenue stability.
- Its retained majority stake in Bausch + Lomb represents substantial embedded value if a clean separation is ultimately achieved.
- The company continues to generate cash flow that it has directed toward incremental debt reduction.
Material Risks & Governance Concerns (Cons)
- A debt burden around $21 billion, with large maturities approaching, creates severe financial and going-concern risk that dominates the investment case.
- The long-delayed Bausch + Lomb separation, solvency-test hurdles, and securities-fraud and fraudulent-transfer litigation signal deep governance and legal overhang.
Related ESG Peer Equities
Companies in Health Care evaluated across carbon intensity, social metrics, and board governance.
ESG & Sustainability Rating Breakdown
Synthesized multi-provider rating across Environmental, Social, and Corporate Governance dimensions.
Audited Methodology
Formal published scorecards from MSCI ESG Research and Sustainalytics are not currently available for this ticker. The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.
Data integrity and methodology
MSCI and Sustainalytics ratings are shown separately with their own observation dates; they are not blended into one score, and providers can disagree. Market quotes are delayed or last-close values, and every snapshot states its source and observation time. Read the full rating methodology.
Financial & Valuation Fundamentals
Core balance sheet and equity valuation metrics sourced from corporate filings.
Audited Financials
Related ESG Financial Tools & Modeling
ESG Investment Growth Calculator
Project compound future portfolio values versus traditional index benchmarks.
Launch Tool →
Portfolio Carbon Footprint Calculator
Translate your investment capital into financed greenhouse gas emissions.
Launch Tool →
Green Mortgage Calculator
Calculate interest rate discounts on energy-efficient certified homes.
Launch Tool →
Featured Sustainable Investment Research & Guides
Top 12 Impact Investing Apps & Platforms (Reviewed)
Comprehensive review of the best ESG micro-investing and direct indexing apps.
Biblically Responsible Investing (BRI): Top Stocks & Funds
Faith-based screening criteria, ESG alignment, and values-based portfolio strategies.
Top Desalination & Clean Water Infrastructure Stocks
Invest in global clean water purification, reverse osmosis, and municipal utilities.
Best Certified B-Corp Banks & Sustainable Banking
How to align your everyday cash reserves with social and climate impact standards.
Frequently Asked Questions
Direct answers on sustainability scores, risk methodologies, and peer rankings.
What is Bausch Health Companies Inc. (BHC)'s ESG rating and sustainability score?
Formal published scorecards from MSCI and Sustainalytics are under ongoing review for Bausch Health Companies Inc. (BHC). The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.
Is Bausch Health Companies Inc. considered an ESG leader or laggard in Health Care?
Independent benchmark status for Bausch Health Companies Inc. is evaluated relative to Health Care peers once third-party coverage publishes official methodology scores.
What are the main ESG risks and controversies for Bausch Health Companies Inc.?
Key material risks for Bausch Health Companies Inc. include: A debt burden around $21 billion, with large maturities approaching, creates severe financial and going-concern risk that dominates the investment case.; The long-delayed Bausch + Lomb separation, solvency-test hurdles, and securities-fraud and fraudulent-transfer litigation signal deep governance and legal overhang.. Investors should evaluate whether corporate mitigation plans adequately address these vulnerabilities.
How does The Impact Investor evaluate ESG stock profiles?
The Impact Investor presents audited third-party ratings from MSCI and Sustainalytics alongside delayed market data and financial fundamentals. We do not blend ratings into proprietary black-box scores, and ratings are never modified by advertising or affiliate relationships.